Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q4 FY25 Earnings Presentation
35 slides from Neogen Chemicals's earnings presentation, May 18, 2025
Slide 1: Exchange filing cover letter for earnings presentation
)( .~aNEOGEN ~~ CHEMICALS LTD. 7' May 18,2025 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Kala Ghoda, Fort Bandra Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai – 4
Slide 2: Q4 & FY25 Earnings Presentation
Creating Opportunities Building a Sustainable Future Q4 & FY25 Earnings Presentation May 2025
Slide 3: Safe Harbor
Safe Harbor Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ ma
Slide 4: Table of Contents
Table of Contents 1 Q4 & FY25 Financial Performance 2 Update on Expansion Initiatives 3 Introduction to Neogen Chemicals 4 Industry Overview – Lithium-Ion Batteries 5 Way Forward 6 CSR Initiatives 7 Contact Us 3
Slide 5: Q4 & FY25 Financial Performance
Q4 & FY25 Financial Performance 4
Slide 6: Key Performance Highlights – Q4 & FY25
Key Performance Highlights – Q4 & FY25 Standalone Consolidated INR in crore Q4 FY25 Revenue break-up** Q4 FY25 FY25 Q4 FY25 FY25 75% 3% 10% 2% 13% Revenues 204 774 203 778 25% 8% 27% 2% 24% EBITDA 41 147 36 136 Domestic *Exports 16% 34% 21% 22% *Including deemed exports PBT 21 80 18 64 90% 69% 12% 8
Slide 7: Financial Summary – FY25
Financial Summary – FY25 Standalone Consolidated REVENUE REVENUE ● Robust volumes in the base business (including BuLi Chem) and incremental contribution from Neogen Ionics fueled revenue growth, while pricing remained soft across product 900 774 900 778 701 691 800 700 800 700 categories 600 600 50
Slide 8: Revenue break-up – Q4 & FY25 (consolidated)
Revenue break-up – Q4 & FY25 (consolidated) 7% 22% Lower Bromine prices Y-o-Y impacted the 666 revenue trajectory. Had they remained Chemicals 200 169 181 700 Organic 180 160 600 544 stable, Organic Revenue for Q4 FY25 140 120 500 would have been higher by ~Rs. 11 crore. And for FY25, it would have
Slide 9: Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) Particulars (Rs. In crore) Q4 FY25 Q4 FY24 Growth (%) FY25 FY24 Growth (%) Revenue 203.8 210.3 -3% 773.7 701.4 10% Expenditure 162.6 172.3 -6% 626.5 585.2 7% EBITDA 41.2 38.0 8% 147.1 116.2 27% EBITDA Margins 20.2% 18.1% +210 bps 19.0% 16.6% +24
Slide 10: Profit & Loss Statement (Consolidated)
Financial Table – Profit & Loss Statement (Consolidated) Particulars (Rs. In crore) Q4 FY25 Q4 FY24 Growth (%) FY25 FY24 Growth (%) Revenue 202.8 199.7 2% 777.6 690.7 13% Expenditure 166.4 163.9 2% 641.2 580.6 10% EBITDA 36.4 35.8 2% 136.3 110.1 24% EBITDA Margins 17.9% 17.9% - 17.5% 15.9% +160 bps
Slide 11: Balance Sheet Snapshot (Consolidated)
Balance Sheet Snapshot (Consolidated) Particulars (Rs. In crore) As on March 31, 2025 As on March 31, 2024 Assets Non-Current Assets 747 678 Current Assets 1,000 784 Total Assets 1,747 1,461 • Total Debt stood at Rs. 566 crore in FY25 Liabilities • Net Debt stood at Rs. 533 crore in FY25 Shareholder
Slide 12: Key Updates – FY25 (Neogen Chemicals)
Key Updates – FY25 (Neogen Chemicals) ● Update on Fire Incident: o Fire at MPP-3 facility, warehouse and tank farms in Dahej SEZ on March 5, 2025 o No injuries or casualties; Other facilities, including Neogen Ionics’ production block, Utilities, etc. unaffected o Losses covered by insurance (assets
Slide 13: Seasonal Variance Factors
Seasonal Variance Factors ● Neogen’s business has some seasonal drivers, due to which the company tends to deliver stronger financial performance in the second half of the financial year (October to March). Seasonal variance is driven by strong demand from Europe as orders tend to scale up in Octobe
Slide 14: Management Commentary
Management Commentary Commenting on the Q4 FY25 performance, Mr. Haridas Kanani, Chairman & Managing Director, at Neogen Chemicals said: "We have closed FY25 on a strong note, achieving 13% revenue growth & 24% improvement in EBITDA. We accomplished this against a difficult & challenging global indu
Slide 15: Historical Financial Trends (Consolidated)
Historical Financial Trends (Consolidated) Net Revenue from Operations** (INR crore) - EBITDA (INR crore) --·-- Margin (%) r-----------J : ,-------------, I CAGR: 21% ~------------- L--------------- I . I 900 800 700 600 500 I I I I I I 336 487 686 691 778 160 140 120 100 18.9% 19.1% 17.8% ·--------
Slide 16: Update on Expansion Initiatives
-r; Update I 1- (, on .• ,,.& t Expansion Initiatives 15
Slide 17: Update on various expansion initiatives
Update on various expansion initiatives Neogen Ionics Proposed Manufacturing Setup Manufacturing locations Land Area Year Planned Capacities Electrolyte Lithium Electrolyte Salts & Additives FY25 2,000 MT 400 MT Dahej SEZ 6,455 m2 FY26 - 2,100 MT Pakhajan, Dahej PCPIR (New site) 264,285 m2 FY26 30,0
Slide 18: Update on Battery Chemicals (Neogen Ionics)
Update on Battery Chemicals (Neogen Ionics) ● Construction Update: Greenfield Facility using MUIS technology (Pakhajan, Dahej PCPIR) o Civil work proceeding swiftly; Erection and engineering phases nearing completion o Modular plant almost completed; the equipment assembly and installation in progre
Slide 19: Introduction to Neogen Chemicals
Introduction to Neogen Chemicals 18
Slide 20: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance ISO 9001:2015, ISO 4 Manufacturing Sites + 246 2 R&D Facilities 13% 14001:2015 & ISO 789 21% 45001:2018 Products Infrastructure Of workforce in Manufacturing units certified on Quality Net worth - FY24 5-year Revenue developed by R&D team & SHE management systems (Rs.
Slide 21: Evolution of Neogen Chemicals
Evolution of Neogen Chemicals 1970’s to 1991 Pre-Neogen 1991 to 2016 Site I 2016 to 2019 Site I & II 2020 to 2024 Multiple Sites ● Mr. HT Kanani graduated as a ● ‘Neogen Chemicals’ ● Acquired Solaris ChemTech ● Doubled Inorganic Chemicals Chemical Engineer and started commenced business Industries’
Slide 22: Key Milestones
Key Milestones Leading manufacturer of Bromine and Lithium-based specialty chemicals since 1989 Signed licensing agreement with Increased the MUIS, Japan Achieved turnover capacity of of ₹100 crore Acquired 100% stake in BuLi Chem Started Inorganic operations with Increased Acquired Chemicals to Rai
Slide 23: Business Overview
Business Overview Organic Chemicals Inorganic Chemicals Bromine Organolithium Advanced Custom The portfolio includes specialty, inorganic lithium-based chemical products Compounds N Butyl Lithium Intermediates Synthesis & which find applications across multiple industries Organic and other Combining
Slide 24: Unique value-proposition
Unique value-proposition Experienced Board of Directors 0 0 0 D,..--...c:::l Cj Specialised Business State-of-the-art Model with High Entry ~ Manufacturing Barriers Facilities ··~ Established Relationship with ~ ®-® -~ ~ Ai Excellent R&D Suppliers Capabilities • 0 o. Enduring Customer uf Innovative
Slide 25: Experienced Leadership Team
Experienced Leadership Team Mr. Shyamsunder Mr. Gopikrishnan Mr. Anurag Surana Upadhyay Sarathy Non-Executive Whole time Director Chief Financial Officer Director ● Holds a bachelor’s ● Holds a master’s ● Associate member of the Mr. Haridas Kanani, Dr. Harin Kanani, PhD degree in commerce degree in
Slide 26: Large Manufacturing Infrastructure – Neogen Chemicals
Large Manufacturing Infrastructure – Neogen Chemicals Strong Manufacturing Infrastructure Factory Land Area Land Utilisation Capacity Certifications of Manufacturing Facilities Organic Chemicals Inorganic Chemicals (Reactor capacity) (Tonnage) ISO 9001:2015 from Bureau Veritas Mahape (Since 1991) 4,
Slide 27: Driving Innovation Through R&D
- Driving Innovation Through R&D Focus on R&D to drive sustained growth; to continue to deploy resources 103-member dedicated R&D 3 CMD and MD actively involved and spend significant time overseeing the team, including 10 Ph. D. 2 4 functioning of both R&D divisions Post commissioning of dedicated R
Slide 28: Key Export Geographies
Key Export Geographies Europe USA China Korea ••Japan Export sales of 28% in FY25 27
Slide 29: Industry Overview Lithium-ion Batteries
Industry Overview Lithium-ion Batteries 28
Slide 30: Strong Opportunities in India's Lithium Battery sector
Strong Opportunities in India’s Lithium Battery sector ● Government’s PLI scheme: Strong demand for locally Lithium-ion battery (3.7v) manufactured batteries is expected to catalyse the growth Approximate Cost Component Break up* of India's EV ecosystem o Target Incentive Outlay of Rs. 18,100 crore
Slide 31: Strong Opportunities in Global Lithium Battery sector
Strong Opportunities in Global Lithium Battery sector Demand Estimates for the Global Market (By 2030) Estimated Battery requirement Estimated Electrolyte demand (KT) Estimated Lithium Salt demand (GWh) (KT) 3,500 3,000 3,500 400 1,125 2,500 350 3,000 2,500 1,500 2,000 300 250 141 2,000 1,500 2,925
Slide 32: Way Forward
Way Forward Expand capabilities in adjacent high-end complex chemistries Augment the Leverage strong R&D capacities of Organic expertise to introduce and Inorganic innovative offerings Chemicals Enhance focus on Deep inroads in CSM & Advanced the Battery Intermediates Materials through portfolio seg
Slide 33: CSR Approach: Focusing On The Greater Good
CSR Approach: Focusing On The Greater Good #NeogenCARES - At Neogen, care isn’t just a commitment. It’s in our DNA. We believe the society is an integral part of our existence. We cannot grow unless the society around us also grows. Our objective, therefore, is to contribute our mite towards socio-e
Slide 34: Contact Us
Contact Us About Neogen Chemicals Limited Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the leading manufacturers of Bromine-based and Lithium- based specialty chemicals. Its specialty chemicals product offerings comprises of Organic as well as In
Slide 35: Thank You
' Thank You \ +